- Home
- ALEC vs AAM Comparison
ALEC vs AAM Comparison
Compare ALEC & AAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- AAM
- Stock Information
- Founded
- ALEC 2013
- AAM 2024
- Country
- ALEC United States
- AAM United States
- Employees
- ALEC N/A
- AAM N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- AAM
- Sector
- ALEC Health Care
- AAM
- Exchange
- ALEC Nasdaq
- AAM Nasdaq
- Market Cap
- ALEC 454.5M
- AAM 440.6M
- IPO Year
- ALEC 2019
- AAM 2024
- Fundamental
- Price
- ALEC $3.76
- AAM $10.05
- Analyst Decision
- ALEC Strong Buy
- AAM
- Analyst Count
- ALEC 5
- AAM 0
- Target Price
- ALEC $20.67
- AAM N/A
- AVG Volume (30 Days)
- ALEC 749.0K
- AAM 95.8K
- Earning Date
- ALEC 11-06-2024
- AAM 01-01-0001
- Dividend Yield
- ALEC N/A
- AAM N/A
- EPS Growth
- ALEC N/A
- AAM N/A
- EPS
- ALEC N/A
- AAM N/A
- Revenue
- ALEC $61,508,000.00
- AAM N/A
- Revenue This Year
- ALEC N/A
- AAM N/A
- Revenue Next Year
- ALEC $118.87
- AAM N/A
- P/E Ratio
- ALEC N/A
- AAM N/A
- Revenue Growth
- ALEC N/A
- AAM N/A
- 52 Week Low
- ALEC $3.49
- AAM $9,600.00
- 52 Week High
- ALEC $8.90
- AAM $15,000.00
- Technical
- Relative Strength Index (RSI)
- ALEC 35.09
- AAM N/A
- Support Level
- ALEC $3.57
- AAM N/A
- Resistance Level
- ALEC $6.14
- AAM N/A
- Average True Range (ATR)
- ALEC 0.48
- AAM 0.00
- MACD
- ALEC -0.20
- AAM 0.00
- Stochastic Oscillator
- ALEC 10.19
- AAM 0.00
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About AAM AA Mission Acquisition Corp. Class A Ordinary Shares
AA Mission Acquisition Corp is a blank check company.